Medicare Enrolled
Dr. Lokesh Bathla, MD
Transplant Surgery Physician · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bathla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bathla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bathla
Dr. Lokesh Bathla is a transplant surgery physician in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bathla performed 5,474 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bathla received a total of $9,103 from 15 pharmaceutical and/or device companies across 34 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bathla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in TX
$9,103 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,474
Medicare services
Top 2% in TX for transplant surgery physician
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,274 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
160 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
129 | $10 | $64 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
91 | $129 | $496 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $95 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
79 | $66 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
60 | $89 | $357 |
| Alpha-fetoprotein (AFP) level test A blood test that measures the amount of alpha-fetoprotein in the serum. This test is used to monitor certain health conditions. |
59 | $16 | $102 |
| Central venous port insertion A surgical procedure to place a small reservoir under the skin for long-term access to the bloodstream. The device is connected to a vein to allow for repeated medication administration or blood draws. |
57 | $254 | $4,202 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
57 | $14 | $69 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $130 | $565 |
| CT scan of abdomen with contrast A CT scan of the abdomen using a contrast dye to create detailed images of internal organs and structures. |
40 | $131 | $793 |
| New patient office visit, complex (60-74 min) | 38 | $162 | $709 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $84 | $372 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $62 | $247 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
25 | $14 | $73 |
| Ultrasound guidance for tissue removal This procedure uses ultrasound imaging to guide the removal of tissue. It provides real-time visual assistance during the extraction process. |
24 | $74 | $342 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
24 | $15 | $76 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $132 | $694 |
| Intraoperative ultrasound guidance Use of ultrasound imaging during a surgical procedure to help guide the surgeon's actions. |
22 | $47 | $205 |
| Liver growth destruction via endoscope This procedure involves destroying abnormal growths in the liver using an endoscope. It is performed to remove or treat the identified growths within the liver tissue. |
21 | $968 | $3,095 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $97 | $470 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
19 | $20 | $128 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
14 | $1,052 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 14 | $86 | $657 |
| Liver procedure using endoscope A procedure performed on the liver using an endoscope, which is a flexible tube with a camera inserted into the body. |
13 | $811 | $2,624 |
| Laparoscopic gallbladder removal Surgical removal of the gallbladder using a small camera and instruments inserted through tiny incisions in the abdomen. |
12 | $489 | $2,390 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
11 | $8 | $36 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,103
Total received (2018-2024)
Avg $1,300/year across 7 years
Top 27% in TX for transplant surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
34
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,787
2023
$656
2022
$340
2021
$1,800
2020
$2,148
2019
$262
2018
$111
Payments by company (2024)
INTUITIVE SURGICAL, INC.
$3,588
Lexington Medical, Inc.
$99
TriSalus Life Sciences, Inc.
$77
AngioDynamics, Inc.
$23
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$3,588
AstraZeneca Pharmaceuticals LP
$2,219
Integra LifeSciences Corporation
$1,800
Stryker Corporation
$367
Boston Scientific Corporation
$190
Sirtex Medical Inc
$144
G1 Therapeutics, Inc.
$125
E.R. Squibb & Sons, L.L.C.
$123
Intuitive Surgical, Inc.
$121
Biocompatibles, Inc.
$111
Lexington Medical, Inc.
$99
TriSalus Life Sciences, Inc.
$77
Varian Medical Systems, Inc.
$62
Braintree Laboratories, Inc.
$53
AngioDynamics, Inc.
$23
Top 3 companies account for 83.6% of all-time payments
Associated products mentioned in payments ›
1688 · ACQUIRE · Aeon Endostapler & Echelon Flex Powered Stapler · COSELA · CUSA CLARITY · DAVINCI XI · Da Vinci Surgical System · FARXIGA · IMFINZI · NANOKNIFE · OPDIVO · SIR-Spheres Microspheres · SUPREP BOWEL PREP · THERASPHERE - BIO · TRINAV INFUSION SYSTEM · TheraSphere Y90 Glass Microspheres 10 GBq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Transplant surgery physicians in nearby ZIP areas
11
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bathla is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bathla experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Bathla performed 4,274 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bathla receive payments from pharmaceutical companies?
Yes. Dr. Bathla received a total of $9,103 from 15 companies across 34 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bathla's costs compare to other transplant surgery physicians in San Antonio?
Dr. Bathla's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bathla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Transplant Surgery Physicians in San Antonio
Browse transplant surgery physicians in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Transplant Surgery Physicians in TX
Transplant surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Transplant Surgery Physicians in TX
Which TX transplant surgery physicians receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Integra LifeSciences Corporation Payments to Doctors
See all physicians who received payments from Integra LifeSciences Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology